2008
DOI: 10.1161/circulationaha.107.725275
|View full text |Cite
|
Sign up to set email alerts
|

Dietary α-Lipoic Acid Supplementation Inhibits Atherosclerotic Lesion Development in Apolipoprotein E–Deficient and Apolipoprotein E/Low-Density Lipoprotein Receptor–Deficient Mice

Abstract: Background-Vascular inflammation and lipid deposition are prominent features of atherosclerotic lesion formation. We have shown previously that the dithiol compound ␣-lipoic acid (LA) exerts antiinflammatory effects by inhibiting tumor necrosis factor-␣-and lipopolysaccharide-induced endothelial and monocyte activation in vitro and lipopolysaccharide-induced acute inflammatory responses in vivo. Here, we investigated whether LA inhibits atherosclerosis in apolipoprotein E-deficient (apoE Ϫ/Ϫ ) and apoE/low-den… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
60
1
6

Year Published

2010
2010
2017
2017

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 88 publications
(70 citation statements)
references
References 49 publications
3
60
1
6
Order By: Relevance
“…Because of the particular cellular pathways influenced by orally administered LA, this compound is now under active consideration as a clinical adjunct for the treatment of diverse pathologies such as hypertension (31), atherosclerosis (59), proinflammatory conditions (23,47), hypertriglyceridemia (3), and diabetes-induced polyneuropathies (43,62). However, it is still unknown whether LA supplementation given over days or weeks at doses appropriate for pharmacological intervention would instigate similar or altogether distinct effects compared with those achieved by acute LA treatment.…”
mentioning
confidence: 99%
“…Because of the particular cellular pathways influenced by orally administered LA, this compound is now under active consideration as a clinical adjunct for the treatment of diverse pathologies such as hypertension (31), atherosclerosis (59), proinflammatory conditions (23,47), hypertriglyceridemia (3), and diabetes-induced polyneuropathies (43,62). However, it is still unknown whether LA supplementation given over days or weeks at doses appropriate for pharmacological intervention would instigate similar or altogether distinct effects compared with those achieved by acute LA treatment.…”
mentioning
confidence: 99%
“…Epidemiological investigation revealed a positive correlation between the severe degree of atherosclerosis and the concentrations of plasma cholesterol as well as LDL (Goldstein et al, 1973;Zhang et al, 2008). After the intake of atherogenic diet that contained high cholesterol, a significant increase of different plasma lipids such as TC and LDL-C with a parallel decrease in HDL was observed compared with that of control group.…”
Section: Discussionmentioning
confidence: 99%
“…Asam alfa lipoat juga mensupresi ekspresi CAM sehingga mencegah selsel darah putih (granulosit, monosit dan limfosit) menempel pada dinding pembuluh darah. 15,17 Adanya pengurangan pembentukan lesi aterosklerosis pada aorta mencit pada penelitian ini juga dapat dihubungkan dengan penurunan kadar kolesterol pada plasma mencit maupun penurunan kadar MDA pada plasma mencit. Asam alfa lipoat dapat menurunkan kadar kolesterol total darah melalui pengaturan aktivitas enzim yang berperan dalam metabolisme kolesterol.…”
Section: Pembahasanunclassified